Adverum Biotechnologies (NASDAQ:ADVM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Adverum Biotechnologies (ADVM) operate in?

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.

Open	$4.33
Close	$4.33
Volume / Avg.	120.37K / 224.58K
Day Range	$4.22 - $4.38
52 Wk Range	4.01 - 29.70
Market Cap	$90.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	6.91%
Days to Cover	6.06

Recent News

Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

Is Adverum Biotechnologies Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adverum Biotechnologies (NASDAQ: ADVM) been one of those stocks this year?

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.33
Close	$4.33
Volume / Avg.	120.37K / 224.58K
Day Range	$4.22 - $4.38
52 Wk Range	4.01 - 29.70
Market Cap	$90.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	6.91%
Days to Cover	6.06

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adverum Biotechnologies (ADVM) stock?

You can purchase shares of Adverum Biotechnologies (NASDAQ:ADVM) through any online brokerage.

View our list of the best stock brokerages

Who are Adverum Biotechnologies (ADVM) competitors?

Other companies in Adverum Biotechnologies’s space includes: Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), Inozyme Pharma (NASDAQ:INZY) and Citius Oncology (NASDAQ:CTOR).

What is the forecast, or price target, for Adverum Biotechnologies (ADVM) stock?

Adverum Biotechnologies has a consensus price target of $24.14.

What is the current price for Adverum Biotechnologies (ADVM)?

The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $4.33 last updated January 17, 2025 at 4:01 PM EST.

Does Adverum Biotechnologies (ADVM) pay a dividend?

There are no upcoming dividends for Adverum Biotechnologies.

When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?

Adverum Biotechnologies’s Q4 earnings are confirmed for Monday, March 17, 2025.

Is Adverum Biotechnologies (ADVM) going to split?

There is no upcoming split for Adverum Biotechnologies.

What sector and industry does Adverum Biotechnologies (ADVM) operate in?

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Adverum Biotechnologies

Adverum Biotechnologies (ADVM) Forecast